An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 115, Issue 12, Pages 1513-1519
Publisher
Springer Nature
Online
2016-11-18
DOI
10.1038/bjc.2016.370
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes – what does it all mean?
- (2015) Helena Earl et al. BMC Medicine
- Critical limitations of prognostic signatures based on risk scores summarized from gene expression levels: a case study for resected stage I non-small-cell lung cancer
- (2015) Lishuang Qi et al. BRIEFINGS IN BIOINFORMATICS
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Application of clinical bioinformatics in lung cancer-specific biomarkers
- (2015) Duojiao Wu et al. CANCER AND METASTASIS REVIEWS
- MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma
- (2015) Yong-Qing Tong et al. Oncotarget
- Individual-level analysis of differential expression of genes and pathways for personalized medicine
- (2014) Hongwei Wang et al. BIOINFORMATICS
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Relative Expression Analysis for Molecular Cancer Diagnosis and Prognosis
- (2014) James A. Eddy et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Measurement of tumour size with mammography, sonography and magnetic resonance imaging as compared to histological tumour size in primary breast cancer
- (2013) Ines V Gruber et al. BMC CANCER
- A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non-Small Cell Lung Cancer Patients
- (2013) H. Tang et al. CLINICAL CANCER RESEARCH
- Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer
- (2012) Ryan K Van Laar BMC Medical Genomics
- Biomarker Discovery in Non-Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation
- (2012) J. Botling et al. CLINICAL CANCER RESEARCH
- Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non-Small-Cell Lung Cancer Patients
- (2011) Y. Xie et al. CLINICAL CANCER RESEARCH
- Prognostic and Predictive Value of a Malignancy-Risk Gene Signature in Early-Stage Non–Small Cell Lung Cancer
- (2011) Dung-Tsa Chen et al. JNCI-Journal of the National Cancer Institute
- Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) L. Crino et al. ANNALS OF ONCOLOGY
- Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma
- (2010) Yun-Sook Kim et al. BMC CANCER
- Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer
- (2010) Chang-Qi Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Expression-Based Prognostic Signatures in Lung Cancer: Ready for Clinical Use?
- (2010) J. Subramanian et al. JNCI-Journal of the National Cancer Institute
- Tackling the widespread and critical impact of batch effects in high-throughput data
- (2010) Jeffrey T. Leek et al. NATURE REVIEWS GENETICS
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
- (2008) Kerby Shedden et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started